Cannabidiol (CBD) could represent a ‘new class of treatment’ for psychosis
A constituent of cannabis could hold promise as a new class of treatment for psychosis, according to King’s College London research showing significant benefits in a clinical trial.
By NIHR Maudsley BRC at 14 Dec 2017